HOME     MY ACCOUNT     POWER SEARCH     REGISTER     MEMBER LIST     SUGGEST CATEGORY  


EntreMed, Inc.

EntreMed, Inc.

http://www.entremed.com/ Researches and develops biopharmaceutical products which address the role of blood and blood vessels in the prevention and treatment of diseases by inhibiting growth or enhancing bioavailability of drugs. Based in Rockville, Maryland. (Nasdaq: ENMD) Biopharmaceuticals > Research and Development EntreMed, Inc. (Nasdaq: ENMD) is a clinical-stage pharmaceutical company developing a new generation of multi-mechanism drugs for the treatment of cancer and inflammatory diseases. EntreMed's drug candidates target disease cells and the blood vessels that nourish them. The Company's goal is to
For detailed information visit the website, please...
entremed   enmd   panzem   2-methoxyestradiol   2me2   tfpi   tissue factor pathway   tissue factor pathway inhibitors   par-2   proteinase activated receptor

Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes

Visitor Rating



Popular Tags

#   A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z  


Google Ads




Other links at Biopharmaceuticals > Research and Development
Develops gene-based therapeutic products derived from adeno-associated virus for the treatment of inherited and acquired diseases. Includes explanation of technology, product pipeline, collaborative partnerships and investment data, from manufacturing facility in Alameda, California. (Nasdaq: AVGN)
Category:

2. Xoma
Development and manufacture of recombinant proteins and peptides, in partnership with big pharmas. Includes licensing of technology derived from the host-defense protein BPI, monoclonal antibodies to treat chemotherapy-induced thrombocytopenia, and to target cancer. Based in Berkeley, California.
Category:

Researches and develops growth factor blockers and anti-cancer vaccines. Includes clinical programs, investor details and overview of company in New York City. (Nasdaq: IMCL)
Category:




Main Category
Join Mailing List
Joining mailing list will entitle you to receive occasional emails informing you of news and updates to the site and any special offers that may be of interest to you.



Top 10
   


Directory Statistics

Links: 1054
Categories: 36


Pagerank Statistics
PR 6
1 site(s)
PR 4
1 site(s)

Yahoo News